SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin launches Solosec oral granules in US market

31 May 2018 Evaluate

Lupin has launched Solosec (secnidazole) 2g oral granules in the US market, having received an approval from the United States Food and Drug Administration (USFDA) earlier.

The company’s Solosec (secnidazole) 2g oral granules is a 5-nitroimidazole antimicrobial agent indicated for the treatment of bacterial vaginosis (BV) in adult women. Solosec, the first new oral antibiotic to treat BV in more than a decade, is designed to deliver a full course of therapy in a single 2g oral dose and is the first and only single-dose oral therapy for BV, the most common vaginal infection in the US among women of childbearing age.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2505.00 15.15 (0.61%)
08-Jul-2026 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1893.65
Dr. Reddys Labs. 1359.80
Cipla 1459.45
Zydus Lifesciences 1170.00
Lupin 2505.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: